XML 22 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current Assets    
Cash $ 169,130 $ 52,937
Prepaid expenses 25,842
Total Current Assets 194,972 52,937
Marketable securities held in Trust Account 58,346,174
Deferred offering costs 314,146
Total Assets 58,541,146 367,083
Current liabilities    
Accounts payable and accrued expenses 46,229
Advance from related party 12,820
Promissory note - related party 390,000
Total Current Liabilities 46,229 402,820
Promissory note - related party 465,641
Deferred underwriting fees 2,012,500
Total Liabilities 2,524,370 402,820
Commitments
Ordinary shares subject to possible redemption, 5,027,689 shares at redemption value 51,016,768
Shareholders' Equity (Deficit)    
Ordinary shares, no par value; unlimited shares authorized; 2,429,811 and 1,437,500 shares issued and outstanding (excluding 5,027,689 and no shares subject to possible redemption) at September 30, 2019 and December 31, 2018, respectively 4,793,207 25,100
Retained earnings/(Accumulated deficit) 206,801 (60,837)
Total Shareholders' Equity (Deficit) 5,000,008 (35,737)
Total Liabilities and Shareholders' Equity (Deficit) $ 58,541,146 $ 367,083